Analog Devices, Inc.

ADI · CIK 0000006281

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$11.02B16.9%

FY2025

Net income (FY)

$2.27B38.7%

FY2025

Free cash flow (FY)

$4.28B37.0%

FY2025

Diluted EPS (FY)

$4.5639.0%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 4.5× since FY2007 · net margin 12.3% → 20.6%

MarginsNet marginFCF margin

FY2025: net 20.6% · free cash flow 38.8% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $4.81B operating cash − $533.6M capex = $4.28B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 10% (FY2009) → 7% (FY2025) · on assets 4.7%

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Revenue	3,623	3,160	2,880	2,640	2,423	2,312	2,159	2,513	3,076	3,263	3,250	3,110
Net income	1,176	831	519	570	391	392	302	463	877	978	961	749
Diluted EPS	2.40	1.69	1.04	1.14	0.78	0.79	0.61	0.93	1.74	1.92	1.88	1.44
Diluted shares	490	492	497	498	499	499	499	499	504	509	511	521
Operating cash flow	—	1,369	—	—	1,127	—	—	1,139	—	—	1,406	—
Capital expenditures	—	109	—	—	149	—	—	223	—	—	176	—
Free cash flow	—	1,259	—	—	978	—	—	916	—	—	1,230	—
Cash & equivalents	2,437	2,906	2,321	2,376	2,350	2,106	1,940	1,304	1,149	1,178	1,670	1,525
Total assets	47,949	47,991	48,193	47,344	47,968	48,618	48,862	48,388	49,347	49,545	50,235	50,346
Shareholders' equity	33,742	33,787	34,086	35,011	35,071	35,190	35,249	35,548	35,904	36,013	36,531	36,639

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.